Use of composite end points to measure clinical events

JAMA. 2003 Sep 17;290(11):1456-7; author reply 1457. doi: 10.1001/jama.290.11.1456-c.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • Clinical Trials as Topic*
  • HIV Infections / drug therapy
  • Humans
  • Treatment Failure*

Substances

  • Anti-HIV Agents